Todd Krueger
Chief Executive Officer AOBiome
Todd Krueger is Chief Executive Officer, President, and Director of Prenetics, where he leads corporate strategy, business development, and overall operations. With more than 20 years of experience in healthcare strategy, finance, and commercialization, he has held leadership roles across biotechnology and life sciences organizations, including Fluidigm Corporation, Life Technologies Corporation, Broad Institute, and Claritas Genomics. A graduate of Northwestern University and its Kellogg School of Management, he also serves on the boards of several innovative biotechnology companies focused on drug delivery, lipid nanoparticle technologies, and microbiome research.
Seminars
Wednesday 11th November 2026
Panel Discussion: Defining Clear Regulatory & Scientific Boundaries Between Consumer & Live Biotherapeutics to Strengthen Investment Confidence
9:00 am
- Differentiating regulatory pathways for direct-to-consumer probiotics versus IND-driven live biotherapeutics to align development strategies with approval expectations
- Evaluating how inconsistent product claims and low-quality evidence create skepticism, reducing investor confidence and complicating partnership decision-making
- Establishing clear scientific, clinical, and quality benchmarks to distinguish credible therapeutics from underpowered products and enable stronger commercial positioning
